Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

EUCRATES BIOMEDICAL ACQUISITION CORP.

(EUCR)
SummaryQuotesChartsNewsCompanyFinancials 
Valuation
Fiscal Period: December 2020
Capitalization1 135
Enterprise Value (EV)1 135
P/E ratio -
Yield -
Capitalization / Revenue -
EV / Revenue -
EV / EBITDA -
Price to Book 27,1x
Nbr of stocks (in thousands) 13 459
Reference price (USD) 10,1
Announcement Date 07/15/2021
1 USD in Million
Income Statement Evolution (Annual data)
Fiscal Period: December 2020
Net sales -
EBITDA -
Operating profit (EBIT)1 -0,45
Operating Margin -
Pre-Tax Profit (EBT)1 -14,8
Net income1 -14,8
Net margin -
EPS -
Dividend per Share -
Announcement Date 07/15/2021
1 USD in Million
Balance Sheet Analysis
Fiscal Period: December 2020
Net Debt1 -
Net Cash position1 0,55
Leverage (Debt / EBITDA) -
Free Cash Flow -
ROE (Net Profit / Equities) -
Shareholders' equity1 -
ROA (Net Profit / Asset) -
Assets1 -
Book Value Per Share2 0,37
Cash Flow per Share2 0,04
Capex -
Capex / Sales -
Announcement Date 07/15/2021
1 USD in Million
2 USD
Key data
Capitalization (USD) 131 899 415
Avg. Exchange 20 sessions () 87 594
Avg. Exchange 20 sessions (USD) 0,00
Average Daily Capital Traded 0,07%
EPS & Dividend